- Home
- PBYI vs SSP Comparison
PBYI vs SSP Comparison
Compare PBYI & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | SSP |
|---|---|---|
| Founded | 2010 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 395.2M |
| IPO Year | N/A | 1988 |
Fundamental Metrics
Financial Performance| Metric | PBYI | SSP |
|---|---|---|
| Price | $5.88 | $4.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.00 | $5.50 |
| AVG Volume (30 Days) | 398.8K | ★ 1.4M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | $211,995,000.00 | ★ $2,318,706,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.11 |
| P/E Ratio | $7.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.58 | $1.36 |
| 52 Week High | $6.12 | $4.98 |
Technical Indicators
Market Signals| Indicator | PBYI | SSP |
|---|---|---|
| Relative Strength Index (RSI) | 63.33 | 47.58 |
| Support Level | $5.51 | $4.27 |
| Resistance Level | $5.73 | $4.98 |
| Average True Range (ATR) | 0.23 | 0.38 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 90.41 | 7.07 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.